Semax
A synthetic peptide approved as a medicine in Russia; not FDA-approved in the United States.
What it is
Semax is Selank's better-known sibling — a synthetic fragment related to ACTH, developed in Russia and holding Russian approval for uses that include stroke recovery and cognitive complaints.
It has decades of Russian clinical literature behind it and essentially no Western regulatory review. The nootropic community adopted it enthusiastically; the evidence a US reader would want — independent randomized trials — doesn't exist.
What researchers have actually studied it for
Stroke recovery and cognitive indications in Russian clinical practice and literature; no FDA review or approval.
How it works
A fragment of ACTH(4-10) with a stabilizing extension, stripped of hormonal (cortisol-stimulating) activity. Proposed actions center on boosting BDNF and modulating dopaminergic and serotonergic signaling — a neurotrophic-support story, built mostly on animal work and Russian clinical series.
Where it came from
Developed by Moscow institutes in the 1980s–90s and registered in Russia in 1996 for stroke and cognitive indications, Semax is standard in Russian neurology — famously in ambulances — while remaining essentially invisible to Western regulators. The nootropics community bridges that gap by mail order.
What the research record actually contains
- Russian clinical studies in stroke recovery and cognitive impairment reporting benefit.
- Animal literature on BDNF elevation and neuroprotection.
- No independent Western RCTs; healthy-adult enhancement — its internet use case — is untested anywhere.
What's known about risks
Reported as well tolerated in Russian practice. No independent characterization; short-term nasal use appears benign in that literature, and the honest phrase remains 'insufficiently studied by independent groups.'
Where it stands legally
A registered Russian medicine; unapproved and unreviewed in the US, circulating through gray-market import.
Worth asking a licensed provider
- 1.For cognitive complaints, what established work-up should come before any compound — sleep, thyroid, depression, medications?
- 2.How should I weigh an evidence base that exists only in another country's literature?
- 3.If neuroprotection interests me, what proven strategies do we have?